Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma

Clinical trial NCT06044506 · RECRUITING

Trial details

NCT number: NCT06044506
Sponsor: Dr Cipto Mangunkusumo General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-08-29
Primary completion: 2026-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.